breast cancer cells
It has been suggested that anti-oestrogen therapy may induce a HER2 signalling       pathway in breast cancer cells and this may cause resistance to anti-oestrogen.
It has been suggested that anti-oestrogen therapy may induce a HER2  @OBJECT$   @PREDICAT$   @SUBJECT$  and this may cause resistance to anti-oestrogen.